Identification of Rare Sugars That Induce FGF21 and Reduce Sugar Appetite in Male BL Mice

Why This Paper Matters

Rare sugars are not just sweet fillers. A new study in Physiological Reports (DOI: 10.14814/phy2.70618) shows they can trigger a liver hormone that changes how mice consume sugar. That shifts the conversation for formulators.

The researchers worked with mouse primary hepatocytes and male BL mice. They identified three compounds—D-allulose, D-tagatose, and D-sorbitol—as potent FGF21 inducers. When the team gave these sugars by intragastric tube, sugar intake dropped. Mixing the sugars into sucrose solutions also reduced intake and preference.

Background

Consumers want sweetness, but they want less sugar. Rare sugars already help because they provide bulk and sweetness with fewer calories. The question has always been whether they do anything more.

This paper suggests yes. FGF21 is a liver-derived hormone. It sits at the center of this study. The authors wanted to know whether rare sugars could induce FGF21 and whether that induction would change sugar-seeking behavior.

What the Study Did

The team started with primary hepatocytes. They screened several candidates for FGF21 induction. D-allulose, D-tagatose, and D-sorbitol stood out as effective.

Then they moved to live animals. They gave the FGF21-inducing rare sugars by oral gavage. They also offered mice sucrose solutions mixed with these sugars. That design separates postingestive effects from taste-related effects.

Key Findings

The behavioral data are clear. FGF21-inducing rare sugars reduced sugar intake. When mixed with sucrose, they reduced both intake and preference.

D-allulose did something especially interesting. It improved palatability while suppressing appetite. It also extended satiety. The net result was lower total intake of the sucrose-containing solution.

Compound	FGF21 induction in hepatocytes	Effect on intake and preference	Additional notes
D-allulose	Potent	Reduced when mixed with sucrose	Improved palatability, suppressed appetite, extended satiety
D-tagatose	Potent	Reduced when mixed with sucrose	Not detailed in the paper
D-sorbitol	Potent	Reduced when mixed with sucrose	Not detailed in the paper

All three compounds induced FGF21. D-allulose got the closest behavioral analysis.

What This Means for Manufacturers

This is early-stage biology, but the direction is useful. A sweetener that reduces the desire for other sugars has clear value in beverages, tabletop sweeteners, and reduced-sugar foods.

Allulose already works as a sugar replacement. This study adds a possible functional layer. If the FGF21 effect translates to humans, allulose might help regulate sugar appetite, not just replace sweetness. D-tagatose and D-sorbitol may offer similar potential, though this paper gives fewer details on their behavior.

Formulators should read the full paper for dose and route specifics. The study used intragastric administration, not simple mixing into food. Gastric delivery and matrix effects will matter when translating this into a product.

FAQ

Were these effects seen in humans?
No. This was a mouse study. Human translation is still unknown.

Does this mean allulose can curb sugar cravings?
It suggests that possibility. The evidence shows reduced sugar intake and preference in mice. Human research is needed.

Should I change my sweetener system based on this?
Not yet. Treat this as a signal, not a specification. Product matrix, target consumer, and regulatory status still drive formulation decisions.

Closing

The next step is human research. If those studies confirm the FGF21 pathway, rare sugars become more than a sweetness solution. They become a tool for appetite control. That is a much bigger opportunity for the food industry.